Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Concordia International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Concordia International Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Concordia International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Concordia International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Concordia International Corp, Medical Devices Deals, 2011 to YTD 2017 10
Concordia International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Concordia International Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Concordia Healthcare Acquires Four Generic Products for USD41 Million 13
Concordia Healthcare Acquires Assets from Covis Pharma for USD1.2 Billion 14
Concordia Healthcare Completes Acquisition Of Donnatal From Revive Pharma For USD265.3 Million 16
Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 18
Pinnacle Biologics Acquires PHOTOFRIN And PHOTOBARR From Axcan Pharma 19
Venture Financing 21
Pinnacle Biologics Raises Funds Through Venture Financing 21
Pinnacle Biologics Secures US$1.5 Million In Venture Financing 22
Private Equity 23
Concordia International May Sell its Minority Stake 23
Cinven Acquires Mercury Pharma from HgCapital for USD730 Million 24
Partnerships 26
Concordia International Enters into Co-Promotion Agreement with RedHill Biopharma 26
Pinnacle Biologics Enters into Distribution Agreement with Orphan Canada for Photofrin 27
Concordia Healthcare Enters Into Distribution Agreement With Lachlan Pharma For Ulesfia Lotion 28
Pinnacle Biologics Enters Into Co-Marketing Agreement With Alkopharma 29
Licensing Agreements 30
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 30
Equity Offering 31
Concordia Healthcare Raises USD520 Million in Public Offering of Shares 31
Concordia Healthcare Raises USD288 Million in Public Offering of Subscription Receipts 33
Concordia Healthcare Completes Public Offering Of Shares For US$61 Million 34
Concordia Healthcare Announces Private Placement Of Securities For US$29 Million 35
Debt Offering 36
Concordia Raises USD266 Million in Public Offering of 9% Notes Due 2022 36
Concordia Healthcare Raises USD790 Million in Private Placement of 9.5% Notes Due 2022 37
Concordia Healthcare Raises USD735 Million in Private Placement of 7% Notes Due 2023 38
Acquisition 39
Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 39
Amdipharm Mercury Acquires Boucher and Muir 41
Amdipharm Mercury acquires Primegen 42
Mercury Pharma Acquires Focus Pharma 43
Concordia Healthcare Acquires Pinnacle Biologics 44
Amdipharm Mercury Acquires Abcur, Specialty Pharma Company 46
Mercari Acquisition To Acquire Concordia Healthcare In Reverse Takeover Transaction 47
Concordia International Corp – Key Competitors 49
Concordia International Corp – Key Employees 50
Concordia International Corp – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Recent Developments 52
Strategy And Business Planning 52
Sep 06, 2017: Concordia International Announces DELIVER Strategy 52
Financial Announcements 53
Nov 14, 2017: Concordia International Announces Third Quarter 2017 Results 53
Aug 11, 2017: Concordia International Announces Second Quarter 2017 Results 57
May 10, 2017: Concordia International Announces First Quarter 2017 Results 61
Mar 15, 2017: Concordia International Announces Fourth Quarter and Fiscal 2016 Results 64
Nov 07, 2016: Concordia International Announces Third Quarter 2016 Results 66
Aug 12, 2016: Concordia International Announces Second Quarter 2016 Results 69
May 13, 2016: Concordia Healthcare Announces First Quarter 2016 Results and Acquisition of Four Products with Global Rights 72
Mar 23, 2016: Concordia Healthcare Announces Fourth Quarter And Fiscal 2015 Results 75
Corporate Communications 78
May 04, 2017: Concordia International Announces Two New Appointments to the Board of Directors 78
Apr 26, 2017: Concordia International Appoints David Price as Chief Financial Officer 79
Jan 04, 2017: RedHill and Concordia sign co-promotion agreement for Donnatal drug promotion 80
Nov 02, 2016: Concordia International announces new leadership appointments 81
Oct 21, 2016: Concordia International Announces CEO Transition Plan 82
Oct 13, 2016: Concordia International Appoints Allan Oberman to Board of Directors 83
Mar 23, 2016: Concordia Healthcare Announces Board Appointment 84
Legal and Regulatory 85
Oct 11, 2017: Concordia International Announces New Communication With CMA 85
Mar 06, 2017: Concordia International Grant of Treble Damages Further Vindicates Marketing Rights of its Donnatal Brand 86
Oct 25, 2016: Concordia International Announces Communication With CMA 87
Government and Public Interest 88
May 31, 2017: Concordia International Announces Results of First CMA Stop/Go Decision 88
Product News 89
06/17/2016: Concordia Healthcare Announces PDT With Photofrin Data And Provides Corporate Update 89
Product Approvals 90
Jun 30, 2016: Concordia International Announces FDA Approval for New Photofrin Laser 90
Other Significant Developments 91
Jun 21, 2017: Concordia International Provides Update on Development of Long-Term Growth Strategy 91
Dec 19, 2016: Concordia International Provides Business Update 92
Aug 03, 2016: Concordia International Confirms That Strategic Review is Ongoing and Provides Update on its Business 93
Jul 13, 2016: Concordia International Provides Additional Disclosure in Relation to Brexit’s Impact on its Business 94
Jun 28, 2016: Concordia Healthcare Announces Name Change To Concordia International And Comments On Brexit’s Impact On The Company’s Business 95
Jan 11, 2016: Concordia Healthcare Provides Corporate Update 96
Appendix 97
Methodology 97
About GlobalData 97
Contact Us 97
Disclaimer 97
Concordia International Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Concordia International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Concordia International Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Concordia International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Concordia International Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Concordia International Corp, Medical Devices Deals, 2011 to YTD 2017 10
Concordia International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Concordia Healthcare Acquires Four Generic Products for USD41 Million 13
Concordia Healthcare Acquires Assets from Covis Pharma for USD1.2 Billion 14
Concordia Healthcare Completes Acquisition Of Donnatal From Revive Pharma For USD265.3 Million 16
Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 18
Pinnacle Biologics Acquires PHOTOFRIN And PHOTOBARR From Axcan Pharma 19
Pinnacle Biologics Raises Funds Through Venture Financing 21
Pinnacle Biologics Secures US$1.5 Million In Venture Financing 22
Concordia International May Sell its Minority Stake 23
Cinven Acquires Mercury Pharma from HgCapital for USD730 Million 24
Concordia International Enters into Co-Promotion Agreement with RedHill Biopharma 26
Pinnacle Biologics Enters into Distribution Agreement with Orphan Canada for Photofrin 27
Concordia Healthcare Enters Into Distribution Agreement With Lachlan Pharma For Ulesfia Lotion 28
Pinnacle Biologics Enters Into Co-Marketing Agreement With Alkopharma 29
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 30
Concordia Healthcare Raises USD520 Million in Public Offering of Shares 31
Concordia Healthcare Raises USD288 Million in Public Offering of Subscription Receipts 33
Concordia Healthcare Completes Public Offering Of Shares For US$61 Million 34
Concordia Healthcare Announces Private Placement Of Securities For US$29 Million 35
Concordia Raises USD266 Million in Public Offering of 9% Notes Due 2022 36
Concordia Healthcare Raises USD790 Million in Private Placement of 9.5% Notes Due 2022 37
Concordia Healthcare Raises USD735 Million in Private Placement of 7% Notes Due 2023 38
Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 39
Amdipharm Mercury Acquires Boucher and Muir 41
Amdipharm Mercury acquires Primegen 42
Mercury Pharma Acquires Focus Pharma 43
Concordia Healthcare Acquires Pinnacle Biologics 44
Amdipharm Mercury Acquires Abcur, Specialty Pharma Company 46
Mercari Acquisition To Acquire Concordia Healthcare In Reverse Takeover Transaction 47
Concordia International Corp, Key Competitors 49
Concordia International Corp, Key Employees 50
Concordia International Corp, Subsidiaries 51